Dichiarazione di accessibilità Salta la navigazione
  • Torna ai siti globali
  • +44 (0)20 7454 5110
  • GDPR
  • Giornalisti
  • Richiedi maggiori informazioni
PR Newswire: news distribution, targeting and monitoring
  • Notizie
  • Prodotti
  • Contatto
When typing in this field, a list of search results will appear and be automatically updated as you type.

Ricerca per il contenuto...

Nessun risultato trovato. Si prega di utilizzare Ricerca avanzata per rivedere la serie completa di contenuti.
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Richiedi maggiori informazioni
    • Telefono

    • +44 (0)20 7454 5110 da 8 AM - 5 PM GMT

    • Contattaci
    • Contattaci

      +44 (0)20 7454 5110
      da 8 AM - 5 PM GMT

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR

New Procedure to Revolutionise Paediatric Ear Surgery Performed for the First Time with AventaMed Solo + Tympanostomy Tube Device (TTD)
  • USA - English
  • Italia - Italiano
  • Portugal - Português


Notizia fornita da

AventaMed

06 gen, 2022, 09:00 GMT

Condividi articolo

Share toX

Condividi articolo

Share toX

CORK, Ireland, Jan. 6, 2022 /PRNewswire/ -- AventaMed DAC, a developer of novel medical devices that streamline surgery, allowing procedures to move out of the operating theatre and into new sites of service such as the doctor's office or clinic, announced the first use of its Solo+ TTD in a paediatric patient while the patient was awake. The procedure was performed by Dr. João Pimentel, a prominent otorhinolaryngologist specialist in Lisbon, Portugal at Hospital da Luz Oeiras.

Immediately after the procedure, Dr. Pimentel said, "The case went very well - even better than I imagined. The child did very well during the brief procedure which lasted less than 5 minutes. The Solo+ performed very well and enabled me to implant a tympanostomy tube in each ear in just a few seconds while the patient was awake. Ear tubes are usually inserted while a child is asleep using general anaesthesia."

Keith Jansen, President and CEO of AventaMed, commented, "This is a huge step forward for the company to be able to help doctors treat children who require ear tubes. The insertion of ear tubes is the most frequently performed surgical procedure on children. Millions of procedures are performed around the world each year. The Solo+ enables doctors to offer patients' families a very significant alternative to what has been performed until now. More and more different types of procedures are being done in an ambulatory setting. Solo+ enables ear tube placements to be done there as well. This should also mean that significant cost savings can be realised for the payers of these procedures."

Dr. Pimentel added, "It is a significant benefit for patients to be able to immediately return to normal activities. Patients, and their families, no longer must wait in a hospital for a prolonged period of time while the patient is prepared for surgery and then recovers from the general anaesthesia. As a result, parents can also return to their normal activities immediately."

About AventaMed:

AventaMed seeks to provide a higher standard of care for the most-frequently performed paediatric surgery in a safer, faster, more cost-effective manner while improving the patient / family experience in a sustainable way.

For more information, contact:
Keith Jansen 
[email protected] 
+1-617-347-6624

Modal title

Contatta PR Newswire

  • +44 (0)20 7454 5110
    da 8 AM - 5 PM GMT

Siti globali

  • APAC
  • APAC - Cinese tradizionale
  • Asia
  • Brasile
  • Canada
  • Ceco
  • Danimarca
  • Finlandia
  • Francia
  • Germania

 

  • India
  • Indonesia
  • Israele
  • Italia
  • Messico
  • Medio Oriente
  • Medio Oriente - Arabo
  • Olanda
  • Norvegia
  • Polonia

 

  • Portogallo
  • Russia
  • Slovacchia
  • Spagna
  • Svezia
  • Regno Unito
  • Stati Uniti

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Siti globali
  • Asia
  • Brasile
  • Canada
  • Ceco
  • Danimarca
  • Finlandia
  • Francia
  • Germania
  • India
  • Israele
  • Italia
  • Messico
  • Medio Oriente
  • Olanda
  • Norvegia
  • Polonia
  • Portogallo
  • Russia
  • Slovacchia
  • Spagna
  • Svezia
  • Regno Uniti
  • Stati Uniti
+44 (0)20 7454 5110
da 8 AM - 5 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.